PCV81 AN ECONOMIC EVALUATION OF THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY IN TERMS OF OPTIMAL LIPID VALUE ATTAINMENT

✍ Scribed by S Balu; RJ Simko; RT Burge; MJ Cziraky; RA Quimbo

• Book ID: 119597231
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 75 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)66379-6